EQL Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is April - March.

Millions SEK. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 12, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	750	1,606	2,064	1,229	1,087	974
Market Cap Growth	-69.82%	-22.15%	67.85%	13.10%	11.64%	-2.05%
Enterprise Value	1,112	1,971	2,205	1,317	1,075	1,010
Last Close Price	25.40	54.40	71.00	42.30	37.40	33.50
PE Ratio	60.48	128.12	47.85	54.15	35.15	30.86
PS Ratio	1.73	3.71	5.53	4.65	4.18	2.38
PB Ratio	2.81	6.02	9.34	6.92	7.02	7.88
P/TBV Ratio	-	-	-	42.91	20.82	38.62
P/FCF Ratio	32.73	70.10	-	-	40.02	23.63
P/OCF Ratio	26.45	56.64	-	-	39.36	23.28
EV/Sales Ratio	2.57	4.56	5.90	4.99	4.14	2.47
EV/EBITDA Ratio	15.89	28.17	29.14	33.94	22.70	24.92
EV/EBIT Ratio	22.83	40.48	32.73	40.38	26.01	26.01
EV/FCF Ratio	48.51	86.00	-	-	39.59	24.52
Debt / Equity Ratio	1.68	1.68	2.06	0.68	0.43	0.62
Debt / EBITDA Ratio	6.41	6.41	5.88	2.98	1.37	1.83
Debt / FCF Ratio	19.57	19.57	-	-	2.45	1.85
Net Debt / Equity Ratio	1.35	1.35	1.69	0.56	0.14	0.28
Net Debt / EBITDA Ratio	5.17	5.17	4.93	2.57	0.47	0.86
Net Debt / FCF Ratio	15.78	15.78	-12.13	-8.06	0.82	0.85
Asset Turnover	0.52	0.52	0.63	0.80	0.99	1.86
Inventory Turnover	1.42	1.42	1.53	1.74	2.69	7.47
Quick Ratio	0.97	0.97	0.97	0.53	0.83	0.77
Current Ratio	1.92	1.92	1.81	1.22	1.43	1.25
Return on Equity (ROE)	5.14%	5.14%	21.63%	13.66%	22.21%	29.37%
Return on Assets (ROA)	3.67%	3.67%	7.12%	6.18%	9.87%	11.00%
Return on Invested Capital (ROIC)	5.31%	5.48%	12.26%	11.40%	19.56%	21.96%
Return on Capital Employed (ROCE)	7.60%	7.60%	11.50%	15.40%	24.50%	27.90%
Earnings Yield	1.67%	0.78%	2.09%	1.85%	2.84%	3.24%
FCF Yield	3.06%	1.43%	-1.49%	-1.01%	2.50%	4.23%
Buyback Yield / Dilution	-0.92%	-0.92%	-0.34%	-0.91%	-1.59%	-